Related Experiment Video
Updated: May 19, 2026
11:54
Microsatellite DNA Genotyping and Flow Cytometry Ploidy Analyses of Formalin-fixed Paraffin-embedded Hydatidiform Molar Tissues
Published on: October 20, 2019
[Partial hydatidiform mole in Morocco: an epidemiological and clinical study]
H Boufettal1, P Coullin, S Mahdaoui
1Service de gynécologie-obstétrique C, Faculté de Médecine et de Pharmacie, Centre hospitalier universitaire lbn Rochd, Casablanca, Maroc. mohcineb@yahoo.fr
Summary
Partial hydatidiform mole (PHM) is a rare pregnancy complication. This study found PHM in 1.4% of abortions, with most patients presenting with bleeding and an enlarged uterus.
Area of Science:
- Reproductive Medicine
- Gynecologic Pathology
- Obstetrics
Context:
- Partial hydatidiform mole (PHM) is a rare gestational trophoblastic disease.
- Accurate diagnosis and management are crucial for patient outcomes.
- Understanding epidemiological and clinical factors aids in early detection.
Purpose:
- To analyze the epidemiological, clinical, therapeutic, and pathological factors of partial hydatidiform mole (PHM).
- To determine the frequency and characteristics of PHM in a specific population.
- To evaluate diagnostic and treatment approaches for PHM.
Summary:
- A retrospective review identified 24 cases of PHM over a decade, with a frequency of 0.4 per 1000 pregnancies.
- Patients typically presented with bleeding and uterine enlargement; diagnosis was confirmed by ultrasound, beta-hCG, and histology.
- Endo-uterine aspiration was the primary treatment, with one case of neoplastic progression successfully managed with chemotherapy.
Impact:
- This study provides valuable data on the incidence and presentation of PHM in the Casablanca region.
- Findings can help clinicians improve diagnostic accuracy and management strategies for PHM.
- Highlights the importance of monitoring for neoplastic sequelae after PHM diagnosis.
